Investigation Overview
May 9, 2014 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) shares, was announced concerning whether the takeover of Chelsea Therapeutics International Ltd. by H. Lundbeck A/S for a value of up to $7.94 per share is unfair to NASDAQ:CHTP stockholders. The investigation by a law fir...
You must register (for free) or login to view the entire investigation.